Source: NutraIngredients

Rebiotix: Ferring & Rebiotix joins MyBiotics in biotherapeutics deal to address vaginal health

Ferring Pharmaceuticals, Rebiotix and MyBiotics Pharma are to enter a research collaboration that focuses on live microbiota-based biotherapeutics to address bacterial vaginosis (BV).

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Lee Jones's photo - President & CEO of Rebiotix

President & CEO

Lee Jones

CEO Approval Rating

89/100

Read more